Close this search box.

 Helping to bring cancer therapies to patients  | Catalyst Clinical Research

Andrew Zupnick, PhD

June 13, 2024

Niche CRO with a difference

Catalyst Oncology is a niche Oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to cancer patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our mission because every second counts for patients and their families living with cancer.

Next-gen Oncology experience

Working largely in early- to mid-phase development across a range of both solid and hematologic indications, we understand the nuances of complex study designs, novel endpoints, and cutting-edge technologies.